Edesa Biotech Cash from Financing (TTM) Analysis

Edesa Biotech Inc (EDSA)

4.420 -0.05 (-1.09%) USD | NASDAQ | Apr 26, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
December 31, 2023	2.224M
September 30, 2023	4.830M
June 30, 2023	4.417M
March 31, 2023	3.676M
December 31, 2022	13.31M
September 30, 2022	11.63M
June 30, 2022	11.85M
March 31, 2022	11.87M
December 31, 2021	13.41M
September 30, 2021	14.17M
June 30, 2021	17.18M
March 31, 2021	17.14M
December 31, 2020	9.043M
September 30, 2020	7.093M
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017

Date	Value
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016	7.313M
June 30, 2016	1.446M
March 31, 2016	1.446M
December 31, 2015	1.446M
September 30, 2015	0.1068M
June 30, 2015	0.1352M
March 31, 2015	0.1503M
December 31, 2014	0.6393M
August 31, 2014	10.79M
May 31, 2014	17.42M
February 28, 2014	18.96M
November 30, 2013	18.55M
August 31, 2013	9.731M
May 31, 2013	3.011M
February 28, 2013	1.482M
November 30, 2012	1.405M
August 31, 2012	0.8772M
May 31, 2012	0.867M
February 29, 2012	0.9385M
November 30, 2011	1.173M
August 31, 2011	5.068M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.224M

Minimum

Dec 2023

17.18M

Maximum

Jun 2021

10.13M

Average

11.74M

Median

Cash from Financing (TTM) Benchmarks